You have 9 free searches left this month | for more free features.

SKLB1028

Showing 1 - 9 of 9

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Newly Diagnosed Acute Myeloid Leukemia (AML) Trial in Chengdu (SKLB1028 Dose Escalation)

Recruiting
  • Newly Diagnosed Acute Myeloid Leukemia (AML)
  • SKLB1028 Dose Escalation
  • Chengdu, China
    West China Hospital of Sichuan University
Jun 30, 2022

Healthy Male Subjects Trial in Shanghai ([14C] SKLB1028)

Completed
  • Healthy Male Subjects
  • [14C] SKLB1028
  • Shanghai, Shanghai, China
    Shanghai Xuhui Central Hospital
May 6, 2022

Healthy Subjects Trial in Beijing (SKLB1028)

Completed
  • Healthy Subjects
  • SKLB1028
  • Beijing, China
    Beijing Friendship Hospital, Capital Medical University
Nov 10, 2021

Advanced Solid Tumors Trial in Zhengzhou (SKLB1028)

Not yet recruiting
  • Advanced Solid Tumors
  • SKLB1028
  • Zhengzhou, Henan, China
    Henan Cancer Hospital
Oct 8, 2021

Healthy Subjects Trial in Beijing (SKLB1028, Midazolam)

Completed
  • Healthy Subjects
  • Beijing, China
    Beijing Friendship Hospital, Capital Medical University
Sep 26, 2021

Healthy Subjects Trial in Beijing (SKLB1028, Itraconazole, Gemfibrozil)

Active, not recruiting
  • Healthy Subjects
  • SKLB1028
  • +3 more
  • Beijing, China
    Beijing Friendship Hospital, Capital Medical University
Sep 26, 2021

Acute Myeloid Leukemia (AML) Trial in Chengdu (SKLB1028, Salvage Chemotherapy)

Recruiting
  • Acute Myeloid Leukemia (AML)
  • SKLB1028
  • Salvage Chemotherapy
  • Chengdu, Sichuan, China
    West China hospital of Sichuan University
Nov 1, 2021

Acute Myeloid Leukemia Trial in Chengdu (SKLB1028 150mg bid, SKLB1028 200mg bid, SKLB1028 300mg qd)

Unknown status
  • Acute Myeloid Leukemia
  • SKLB1028 150mg bid
  • +2 more
  • Chengdu, Sichuan, China
    West China Hospital,Sichuan University
Jul 12, 2019

Acute Myeloid Leukemia Trial in Chengdu (SKLB1028)

Unknown status
  • Acute Myeloid Leukemia
  • SKLB1028
  • Chengdu, Sichuan, China
    West China Hospital,Sichuan University
Aug 4, 2016